is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
New virtual event ‘CPhI: Festival of Pharma’ introduced. Following discussions with key partners and industry stakeholders, the CPhI Worldwide in-person event is now confirmed to return in 2021, with the 2020 edition in Milan not taking place. Responding to the need to connect + collaborate in today’s pharmaceutical industry, CPhI is excited to present you with the CPhI: Festival of Pharma, a new virtual extravaganza for the global pharma community.
The ongoing pandemic has fuelled debate about whether Western pharmaceutical supply chains and API sourcing are too dependent on lower-cost Asian suppliers such as China. Do the US and Europe need to bring manufacturing back home?
Players in the pharmaceutical value chain will need to fully harness cutting-edge digital technologies such as artificial intelligence (AI) and cyber-security solutions to make greater efficiency...
South Africa and Kenya represent the best opportunities for pharmaceutical manufacturing firms thinking of investing in Sub-Saharan Africa, according to Martin Tronquit, Managing Partner at data...
The CPhI Annual Report is a comprehensive and critically important publication that analyses key trends and innovations forecast by our panel of world class experts, as well as the CPhI Pharma Industry Rankings (an annual executive survey of pharma professional).
Now in its eighth year and launched at the CPhI Festival of Pharma, the report is an essential read for executives looking to get a head-start today on the shape of tomorrow’s industry.
The CPhI Annual Report is a comprehensive and critically important publication that analyses key trends and innovations forecast by our panel of world class experts.
Running as a series of opinions and articles, the CPhI experts call upon their considerable commercial and technical acumen to prophesize the future direction, technologies, opportunities and threats in pharma. It’s an essential read for executives who wish to get a head start today on the shape of tomorrow’s industry.
We are at a crucial point in pharma manufacturing as newer technologies and changing pipelines, in addition to demand for lower cost drugs, join forces to change how drugs will be manufactured in the future. This marks the beginning of an age of smart pharma manufacturing, as the industry takes centre stage in advancing medicine.
Find out how changing pipelines of smaller volume drugs, coupled with new technologies, not only transform industry attrition rates, but also change the machinery used in pharma manufacturing.